GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Olipass Corp (XKRX:244460) » Definitions » Common Stock

Olipass (XKRX:244460) Common Stock : ₩2,351.6 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Olipass Common Stock?

Olipass's quarterly common stock increased from Jun. 2024 (₩17,994.8 Mil) to Sep. 2024 (₩20,145.4 Mil) but then declined from Sep. 2024 (₩20,145.4 Mil) to Dec. 2024 (₩2,351.6 Mil).

Olipass's annual common stock increased from Dec. 2022 (₩14,666.1 Mil) to Dec. 2023 (₩15,426.2 Mil) but then declined from Dec. 2023 (₩15,426.2 Mil) to Dec. 2024 (₩2,351.6 Mil).


Olipass Common Stock Historical Data

The historical data trend for Olipass's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Olipass Common Stock Chart

Olipass Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,227.50 13,081.79 14,666.09 15,426.20 2,351.62

Olipass Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15,426.20 15,620.30 17,994.79 20,145.37 2,351.62

Olipass Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Olipass Business Description

Traded in Other Exchanges
N/A
Address
16-4, 16 Beon-gil, Dongbaek Jungang-ro, Ace Dongbaek Tower 20th Floor, Giheung-gu, Yongin, KOR, 17015
Olipass Corp is a South Korea based biotechnology company engaged in developing its platform OliPass PNA which focuses on introducing cationic lipid moiety onto nucleobase. Its pipeline products include SC Injection, Hyper Cholesterolemia, Chemo/Radio-sensitizer, and Type II Diabetes among others.

Olipass Headlines

No Headlines